tiprankstipranks
Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
PremiumPress ReleasesAridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
9M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
10M ago
Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
PremiumPress Releases
Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
10M ago
Aridis Pharmaceuticals receives Nasdaq notice on late filing of Form 10-K
PremiumThe FlyAridis Pharmaceuticals receives Nasdaq notice on late filing of Form 10-K
1y ago
Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K
PremiumPress Releases
Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K
1y ago
Aridis Provides Corporate Update
PremiumPress Releases
Aridis Provides Corporate Update
1y ago
Aridis meets primary, secondary endpoints in Phase 2a study of AR-501
PremiumThe FlyAridis meets primary, secondary endpoints in Phase 2a study of AR-501
1y ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
Aridis Pharmaceuticals price target lowered to $10 from $19 at H.C. Wainwright
PremiumThe Fly
Aridis Pharmaceuticals price target lowered to $10 from $19 at H.C. Wainwright
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100